Pfizer Ltd.
BSE: 500680 | Sector: Health care |
NSE: PFIZER | ISIN Code: INE182A01018 |
BSE 10:05 | 05 Jul | 4139.15 |
35.20 (0.86%) |
OPEN
4109.00 |
HIGH
4139.15 |
LOW
4094.65 |
NSE 09:54 | 05 Jul | 4130.00 |
28.30 (0.69%) |
OPEN
4100.00 |
HIGH
4140.00 |
LOW
4090.20 |
OPEN | 4109.00 |
PREVIOUS CLOSE | 4103.95 |
VOLUME | 204 |
52-Week high | 6164.80 |
52-Week low | 4056.00 |
P/E | 30.91 |
Mkt Cap.(Rs cr) | 18,937 |
Buy Price | 4134.45 |
Buy Qty | 2.00 |
Sell Price | 4139.15 |
Sell Qty | 1.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Pfizer Ltd. (PFIZER) - Nine Monthly Result
Particulars (![]() |
Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 |
Net Sales/Income From Operations | 2061.33 | 1703.79 | 1649.64 | 1545.84 | 1448.56 |
Other Income | 45.53 | 43.92 | 138.80 | 131.94 | 83.06 |
Total Income | 2106.86 | 1747.71 | 1788.44 | 1677.78 | 1531.62 |
Total Expenditure | 1391.05 | 1117.41 | 1185.79 | 1131.63 | 1086.73 |
Operating Profit | 715.81 | 630.30 | 602.65 | 546.15 | 444.89 |
Interest | 6.64 | 11.57 | 7.23 | 0.68 | 0.54 |
Gross Profit | 709.17 | 618.73 | 595.42 | 545.47 | 444.35 |
Depreciation | 81.39 | 82.10 | 74.83 | 53.78 | 48.98 |
PBT | 627.78 | 536.63 | 520.59 | 491.69 | 395.37 |
Tax | 167.40 | 144.56 | 145.27 | 182.61 | 155.74 |
Net Profit/(Loss) | 486.77 | 397.06 | 406.12 | 319.58 | 255.56 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 486.77 | 397.06 | 406.12 | 319.58 | 255.56 |
Equity Share Capital | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 106.40 | 86.79 | 88.77 | 69.85 | 55.86 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Pfizer:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices